A股異動丨中信特鋼(000708.SZ)市值超寶鋼 成為A股市值最高鋼企
格隆匯2月3日丨中信特鋼(000708.SZ)近期不斷走強,今日再漲6.42%,報32.53元,股價刷新歷史新高,總市值攀升至1641億元,超過寶鋼股份的1485億元,成為A股市值最高鋼企。國泰君安上個月發佈研報稱,公司特鋼產品主要走高端路線,充分受益製造業升級及進口替代的歷史機遇,產品需求潛力巨大。公司作為全球特鋼龍頭,國內市佔率近20%,競爭格局一家獨大,疊加公司產品力、服務力、研發力均行業領先,品牌效應、規模優勢和先發優勢明顯,護城河深厚,公司有望伴隨特鋼行業市場規模的逐步擴張而不斷成長。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.